Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous Syringe

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2015
The primary objective of the study is to compare, in patients treated with methotrexate injection for rheumatoid arthritis, the compliance and the health assessment questionnaire evolution for the administration by auto-injector versus administration by conventional subcutaneous injection, after 6 months of treatment.
Epistemonikos ID: 5076768b37eacc81220afb818fa8f1381415db6a
First added on: Mar 23, 2022